All4NutraNo products in the cart.
All4NutraStartseite » Oral Excipients » Page 45
The aim of this study is to investigate the potential of hybrid polymer-lipid microparticles with a biphasic structure (b-MPs) as...
Oral multiparticulate systems are often the ‘go to’ solution for flexible dosing, especially in cases where a degree of functionality,...
Abstract Lipid-based formulation (LBF) has attracted more and more attention as it can significantly improve the efficiency of oral delivery...
Despite several novel and innovative approaches, clinical translation of oral insulin delivery into commercially viable treatment is still challenging due...
Odoribacter (O.) splanchnicus is an anaerobic member of the human intestinal microbiota. Its decrease in abundance has been associated with inflammatory...
A multi-national online survey was developed to obtain feedback on users’ experiences of administration devices for oral and inhaled paediatric...
An International Guideline for the Preparation, Care and Use of Medicinal Products See the new book, edited by Paul Le...
The main purpose of this study was to optimise the conditions for synthesizing diosgenin-encapsulated chitosan nanoparticles (DIO@CS NPs) and anticancer...
ABSTRACT Introduction Increasing attention is being afforded to understanding the bidirectional relationships that exist between oral medications and the gut...
Galeterone, a novel prostate cancer candidate treatment, was discontinued after a Phase III clinical trial due to lack of efficacy....
Copyright: PharmaExcipients AG